Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2025-12-27 @ 11:03 PM
Study NCT ID:
NCT00967993
Status:
COMPLETED
Last Update Posted:
2014-12-05
First Post:
2009-08-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease
Sponsor:
Keryx Biopharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
KRX-0502-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None